APA (7th ed.) Citation

E, L., CC, C., M, B., S, I., YC, K., M, S., . . . AJ, A. (2022). Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET. Molecular pharmaceutics, 19(8), 2971. https://doi.org/10.1021/acs.molpharmaceut.2c00359

Chicago Style (17th ed.) Citation

E, Lambidis, Chen CC, Baikoghli M, Imlimthan S, Khng YC, Sarparanta M, Cheng RH, and Airaksinen AJ. "Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET." Molecular Pharmaceutics 19, no. 8 (2022): 2971. https://doi.org/10.1021/acs.molpharmaceut.2c00359.

MLA (9th ed.) Citation

E, Lambidis, et al. "Development of 68Ga-Labeled Hepatitis E Virus Nanoparticles for Targeted Drug Delivery and Diagnostics with PET." Molecular Pharmaceutics, vol. 19, no. 8, 2022, p. 2971, https://doi.org/10.1021/acs.molpharmaceut.2c00359.